NCT03759964View on ClinicalTrials.gov

Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

December 15, 2018

Primary Completion Date

December 9, 2020

Study Completion Date

January 2, 2021

Conditions
Anemia, Iron Deficiency
Interventions
DRUG

Ferric carboxymaltose

1g of Ferric carboxymaltose diluted in 100 mL of IV isotonic serum saline at day 1 following surgery

DRUG

Placebo

100 mL of IV isotonic serum saline at day 1 following surgery

Trial Locations (1)

166830

Hotel Dieu de France Hospital, Beirut

Sponsors

Collaborators (1)

Vifor Pharma
All Listed Sponsors
collaborator

Vifor Pharma

INDUSTRY

collaborator

Saint-Joseph University

OTHER

lead

St Joseph University, Beirut, Lebanon

OTHER

NCT03759964 - Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery | Biotech Hunter | Biotech Hunter